Improvements in chronic peripancreatic adipose tissue inflammation, leptin, hyperinsulinemia, T2DM, KRAS activation, IGF and intestinal microbiome after dietary intervention and bariatric surgery may explain the decreased development of pancreatic ductal adenocarcinoma after bariatric surgery [116]. The gene discussed is IGF1; the disease is pancreatic ductal adenocarcinoma.